Striatal Neurons In Multiple System Atrophy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Cell Type | Striatal Neurons |
|---|---|
| Disease | Multiple System Atrophy (MSA) |
| Region | Basal Ganglia / Striatum |
| Neurotransmitter | GABA + Dopamine |
| Classification | Medium Spiny Neurons, Interneurons |
The striatum is the primary input nucleus of the basal ganglia, comprising the caudate nucleus and putamen. In multiple system atrophy (MSA), a sporadic neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia, striatal neurons undergo significant degeneration. This contributes to the prominent parkinsonian features that distinguish MSA from other parkinsonian disorders.
The striatum contains several neuronal populations:
Medium Spiny Neurons (MSNs) - 90-95% of striatal neurons
Striatal Interneurons:
Striatal neurons:
MSA is classified as a synucleinopathy with:
MSA presents in two major variants:
MSA-C (Cerebellar): Predominant cerebellar ataxia
MSA-P (Parkinsonian): Predominant parkinsonism
Parkinsonism: Bradykinesia, rigidity, tremor
Movement disorders:
Striatal involvement contributes to:
Symptomatic treatment:
Supportive care:
Disease-modifying therapies:
Cell replacement: Stem cell-based approaches (experimental)
The study of Striatal Neurons In Multiple System Atrophy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12(2):133-147. DOI:10.1002/mds.870120203
Jellinger KA. Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Mov Disord. 2014;29(14):1720-1741. DOI:10.1002/mds.26052
Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med. 2015;372(14):1375-1378. DOI:10.1056/NEJMra1311488
Koga S, Dickson DW. Neuropathology of multiple system atrophy: an update. J Neurol Neurosurg Psychiatry. 2022;93(11):1169-1177. DOI:10.1136/jnnp-2022-329274
Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163(1):94-98. DOI:10.1016/s0022-510x(9900027-7
Related cell types: Medium Spiny Neurons in Huntington's Disease, Oligodendrocytes in MSA